Missed the 2024 Biopharma
Partner Symposium?
Hear From Genedata Customers at the 2024 Partner Symposium
AstraZeneca
Janssen
Pfizer
GSK
Sanofi
Novartis
Abbvie
Roche
AstraZeneca
Ferring
Janssen
Novartis
Merck
Daiichi Sankyo
Biotalys
Sartorius
AstraZeneca
UCB
AstraZeneca
Debiopharm
Charles River
2025 Genedata Biopharma Partner Symposium | Boston, USA | Exact Date TBC
The annual Genedata Biopharma Partner Symposium is a unique interdisciplinary event at the interface between biopharma R&D and IT. Presentations and discussions will focus on innovative applications and new industry requirements: novel molecular formats (e.g., multispecifics, TCRs, CARs, AAVs, RNA vaccines), advanced screening technologies, MS-based multi-attribute methods (MAM), NGS, molecular patient profiling, and automation and data FAIRification in biopharmaceutical R&D.
At this invitation-only event, leading biopharma companies will show how groups have set up, operate, and use Genedata solutions to transform their biotherapeutics research & development and how this results in increased efficiency and throughput. The symposium brings together people working in all areas of biopharma:
- Discovery—Screening, selection, engineering, and validation
- Development—Characterization, optimization, and cell-line engineering
- Production—Bioprocessing, biosafety, and QC
- Translational Science—Patient profiling and integrative (pre-)clinical research
- IT—Infrastructure, networking, and integration
- Automation—Laboratory, data and research process automation
A Roundup of the 2024 Partner Symposium
Are You a Genedata Customer?
Secure Your Spot for the 2025 Genedata Biopharma Partner Symposium.
2024 Agenda Recap
Day 1 — Wednesday, March 6, 2024 | |||||||
Plenary Session | |||||||
8:30–9:00 | Registration & Welcome Coffee Hyperion Hotel Basel, Messeplatz 12, Basel, Switzerland | ||||||
9:00–9:10 | Opening Remarks Jana Hersch, Head of Corporate Scientific Engagement, Genedata, Boston, MA, USA | ||||||
9:10–9:30 | Work Smarter, Not Harder: Leveraging Data to Increase Efficiency Othmar Pfannes, CEO, Genedata, Basel, Switzerland | ||||||
9:30–10:00 | Evolution of the Genedata Biologics Ecosystem at Pfizer: RNA and Beyond Joel Bard, Associate Research Fellow BioMedicine Design, Pfizer, Cambridge, MA, USA | ||||||
10:00–10:30 | Genedata Expressionist at the Biologics Research Center, Novartis Basel: Automating and Digitalizing MS Analytics Patrick Schindler, Senior Principal Scientist, Novartis, Basel, Switzerland | ||||||
10:30–11:00 | Break | ||||||
11:00–11:30 | Embracing Change: Digitalizing Antibodies, Cell & Gene Therapies, and More at AstraZeneca Carl Matthews, Principal Scientist Biologics Engineering, AstraZeneca, Great Abington, United Kingdom | ||||||
11:30–12:00 | Digitalizing ADC Workflows with Genedata at Merck Sameh Eid, Principal Scientist Research Informatics, Merck, Darmstadt, Germany | ||||||
12:00–12:30 | Streamlining Lab Execution Workflows with Genedata Rik Rademaker, Director Cell and Molecular Sciences, Genmab, Utrecht, The Netherlands | ||||||
12:30–2:00 | Lunch Hyperion Hotel Basel | ||||||
Breakout Sessions | |||||||
BIOTHERAPEUTICS DISCOVERY & DEVELOPMENT Biologics & Bioprocess | ASSAY ANALYSIS & MANAGEMENT Screener | MASS-SPEC DATA ANALYSIS Expressionist | PRECISION MEDICINE Profiler | NGS-BASED DEVELOPMENT & BIOSAFETY Selector | |||
2:00–2:30 | Genedata Biologics at the Center of Sanofi’s Large Molecules Research | High-Throughput Screening of NANOBODY® Molecules Using a Genedata Screener – Biologics Integrated Workflow | Genedata at Janssen: A Brief History, Current and Future Directions with Focus on Genedata Expressionist | From Lab Automation to Data Standardization and Modeling | From Sequences to Insights: Genetic Characterization of Cell Lines Using NGS Benjamin Lindner, Senior Data Scientist, Boehringer Ingelheim, Biberach, Germany | ||
2:30–3:00 | Leveraging Genedata Biologics in the Discovery and Characterization of TCRs for Adoptive Cell Therapy Lisa Eisenberg, Senior Scientist Machine Learning, Immatics Biotechnologies, Tübingen, Germany | Efficient Analysis of Drug Combination in Oncology Therapeutic Discovery | Peptide Mapping for the Masses: Rolling Out Data Processing to Less Experienced Users Will Burkitt, Associate Director, UCB, Slough, United Kingdom | Expanding the Genedata Biopharma Platform with Self-Service Data Science Andreas Biegert, Software Engineering Lead, Genedata, Munich, Germany | Path to Fully Automated NGS Assays with Playbooks Ludwig Macko, Head of Genedata Selector Development, Genedata, Basel, Switzerland | ||
3:00–3:30 | A Lean and Smart Approach for Setting Up an Antibody Development Platform Gregory Mouret, USP Scientist, Ferring Biologics Innovation Centre, Lausanne, Switzerland | Genedata Screener 21 Further Accelerates Project Cycles and Elevates Output Quality Matthias Fassler, Product Manager Genedata Screener, Genedata, Basel, Switzerland | Streamlining Data Analysis in LC-MS MAM Workflows Patrick Merkle, Senior Expert, Novartis, Basel, Switzerland | Deciphering the Immune System's Complexity with Single-Cell and Spatial Analysis | NGS Implementation for Adventitious Virus Detection – from Investigation to Quality Control Aurora Signorazzi, Scientist & Project Leader, Janssen, Leiden, The Netherlands | ||
3:30–4:00 | Unifying Antibody Library Workflows Including NGS Analysis in Genedata Biologics Nathalie George, Investigator, Novartis, Basel, Switzerland | A Window to the RNA Landscape: Optimizing Analysis of Gene Expression Assays at Axxam | Genedata Expressionist at Biologics Research Center (BRC) Basel Christian Hug & Emilie Muller, Heloise Hensinger & Thierry Besson, Novartis, Basel, Switzerland | The NGS Analysis Pipelines for Virus Detection in Biologics Izabela Fabianska, Scientist Development Analytics, IDT Biologika, Dessau-Rosslau, Germany | |||
4:00–4:15 | Break | ||||||
4:15–5:30 | Demo and Poster Session Meet the Experts – Check out our demos and view posters. Demos are approximately 5–10 minutes and will be repeated on demand throughout the session. | ||||||
Breakout Sessions | |||||||
BIOTHERAPEUTICS DISCOVERY & DEVELOPMENT Biologics & Bioprocess | NGS-BASED DEVELOPMENT & BIOSAFETY Selector | ||||||
5:30–6:00 | Automation of Upstream Process Development in Genedata Bioprocess at Biotalys | Enabling the Validation of NGS-Based Characterization and Release Assays | |||||
6:00–6:30 | Roadmap Genedata Biologics & Genedata Bioprocess Christoph Freiberg, Head of Science, Genedata, Basel, Switzerland Guido Cappuccilli, Product Manager, Genedata, Basel, Switzerland | Panel Discussion: NGS in an Evolving Regulatory Landscape | |||||
7:00 | Dinner Restaurant Kunsthalle, Steinenberg 7, 4051 Basel |
Day 2 — Thursday, March 7, 2024 | |||
Plenary Session | |||
8:00–8:45 | Welcome Coffee Hyperion Hotel Basel, Messeplatz 12, Basel, Switzerland | ||
8:45–9:00 | Opening Remarks Jana Hersch, Head of Corporate Scientific Engagement, Genedata, Boston, MA, USA | ||
9:00–9:30 | Analytical Tools for Modern Integrated Drug Discovery Jonathan Wingfield, Principal Scientist, AstraZeneca, Cambridge, UK | ||
9:30–10:00 | Automating MS-Based Bioanalytics Workflows with Genedata at Novartis Felix Stemmer, Senior Scientist II, and Martin Jockel, Senior Expert I Data Science, Novartis, Basel, Switzerland | ||
10:00–10:30 | Break | ||
10:30–11:00 | AI-Based Digital Pathology Image Classification Sven-Eric Schelhorn, Associate Director Oncology Data Science, Merck, Darmstadt, Germany | ||
11:00–11:30 | GSK’s Biopharma Data Platform for End-to-End Data Science, Analytics, and Lab Automation Workflows Thil Batuwangala, Director Data Sciences – Large Molecule Discovery, and Przemyslaw Stasica, Biopharma Discovery Data Designer, GSK, Stevenage, United Kingdom | ||
11:30–12:00 | Discovery & Optimization of Biotherapeutics — towards Higher Throughput Peptide Mapping Using Mass Spectrometry Jennifer Kuehn, Lab Head Assays & Analytics, Sanofi, Frankfurt am Main, Germany | ||
12:00–12:45 | Panel Discussion — Beyond Automation: How to Build a Corporate Culture of Data Quality | ||
12:45–2:00 | Lunch Hyperion Hotel Basel | ||
Breakout Sessions | |||
BIOTHERAPEUTICS DISCOVERY & DEVELOPMENT Biologics & Bioprocess | ASSAY ANALYSIS & MANAGEMENT Screener | MASS-SPEC DATA ANALYSIS Expressionist | |
2:00–2:30 | AbbVie Digitalization Journey with Genedata Sukru Kaymakcalan, Director of Information Research and Technology Solutions, AbbVie, Worcester, MA, USA | High Dimensional Analysis of Cell Paint Data in Genedata Screener | Unraveling the Complete Picture of Disulfide Linkages in IgGs Sipke Sangers, Principal Scientist Analytical Sciences Mass Spectrometry, Genmab, Utrecht, The Netherlands |
2:30–3:00 | Our Journey Deploying Genedata Biologics at ADC Therapeutics Christopher Gallagher, Associate Director, ADC Therapeutics, London, United Kingdom | Accelerating Time to Market through Digitalization of Automation Workflows Sascha Fischer, Business Development Manager, Genedata, Switzerland | Investigation of In Vivo Biotransformations of Biotherapeutics in Mouse Plasma Using Intact and Middle-Down MS Jonathan Dhenin, Senior Scientist Metabolism DMPK Research Platform, Sanofi, Paris, France |
3:00–3:30 | Break | ||
3:30–4:00 | Integration of Genedata Bioprocess with CellCelector for Increasing Automation and Throughput in Sartorius’ CLD Platform Markus Sanna, Manager Digital Data Excellence and IT Services, Sartorius, Ulm, Germany | Novel Analysis Methodology Using Genedata Screener to Understand Neuronal Phenotypes on Multi-electrode Array (MEA) Amy Brook, Associated Research Leader, Charles River Laboratories, Saffron Walden, United Kingdom | Tailored MS Data Processing Workflows for Analyzing ADCs from Hit Discovery to Lead Optimization |
4:00–4:30 | Bispecific Antibodies at Light Chain Bioscience — from Discovery to Clinical Development Walter Ferlin, CSO, Light Chain Bioscience, Geneva, Switzerland | Towards an Integrated Platform for Chromatography Data Analysis and Management | Customized Activity Development for Routine Leachables Analysis: A Case Study in the Hyphenated & Special Technology Group at Roche Nicolas Wernli, Technical Lead, and Covadonga Palacio Gutierrez, Scientist, Roche, Basel, Switzerland |
End of Symposium |
Participants in previous Genedata symposia have included:
Interested in learning more about our previous symposia?
View the agenda and participants from the 2023 symposium
Register Your Interest For 2025
Having trouble viewing the form? Please contact us by email at symposium(at)genedata.com.